Literature DB >> 26668614

Use of a correlation analysis model in the optimization of intensity-modulated radiotherapy of prostate cancer.

Xiadong Li1, Qinghua Deng1, Shenglin Ma2, K E Zhang2, Zhibing Wu2, Jianjun Lai2, Rongjun Tang2, Yao Ren2, Jiahao Wang2, Lixia Xu2.   

Abstract

The aim of the present study was to develop a statistical model-based method for the optimization of intensity-modulated radiotherapy (IMRT). A prostate cancer IMRT plan was redesigned while retaining the same beam orientation and prescribed dose as the regular plan. A series of dosimetric parameters were generated, and a 4-step protocol was performed to analyze the data: i) The tumor control probability of the target was ensured by setting a number of strict constraint parameters so that much of the target was covered by the 95% isodose line; ii) the parameters for optimization [weight ratio, equivalent characteristic parameter a and maximum equivalent uniform dose of the organ at risk (OAR)] were adjusted; iii) the overall optimization space (OOS) was determined via analysis of the dose-parameter tables based on the correlation factor (CF) and optimization efficiency factor analysis; iv) the OOS in the Pinnacle V7.6 treatment planning system with IMRT function was transposed. A selected optimization phenomenon existed when different optimization methods were used to optimize dose distribution to the targets and OARs, which demonstrates a wide variation in the CFs between the percentage of planning target volume receiving 95% of the prescribed dose and the maximum dose of the bladder, rectum and femur. The OOS used to optimize the randomly selected plan exhibited relatively high efficiency, with benefits for the optimization of IMRT plans. For patients with prostate cancer who require complex IMRT plan optimization, the obtained OOS from the two core analysis techniques is likely to have relatively high efficiency in achieving an optimized plan. These results suggest that the correlation analysis model is a novel method for the optimization of IMRT for prostate cancer.

Entities:  

Keywords:  correlation analysis; equivalent uniform dose prostate cancer; intensity-modulated radiotherapy; optimization design

Year:  2015        PMID: 26668614      PMCID: PMC4670970          DOI: 10.3892/etm.2015.2834

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  12 in total

1.  Combination of IG-IMRT and permanent source prostate brachytherapy in patients with organ-confined prostate cancer: GU and GI toxicity and effect on erectile function.

Authors:  Vladimir Valakh; Alexander Kirichenko; Ralph Miller; Tara Sunder; Lindsay Miller; Russell Fuhrer
Journal:  Brachytherapy       Date:  2010-10-28       Impact factor: 2.362

2.  A new dose-volume-based Plan Quality Index for IMRT plan comparison.

Authors:  Lucullus Hing Tong Leung; Monica Wai Kwan Kan; Ashley Chi Kin Cheng; Wicger King Hang Wong; Chun Chung Yau
Journal:  Radiother Oncol       Date:  2007-11-26       Impact factor: 6.280

3.  The likelihood of death from prostate cancer in men with favorable or unfavorable intermediate-risk disease.

Authors:  Florence K Keane; Ming-Hui Chen; Danjie Zhang; Marian J Loffredo; Philip W Kantoff; Andrew A Renshaw; Anthony V D'Amico
Journal:  Cancer       Date:  2014-03-06       Impact factor: 6.860

Review 4.  Radiation dose-volume effects in radiation-induced rectal injury.

Authors:  Jeff M Michalski; Hiram Gay; Andrew Jackson; Susan L Tucker; Joseph O Deasy
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-03-01       Impact factor: 7.038

5.  Equivalent uniform dose for accelerated partial breast irradiation using the MammoSite applicator.

Authors:  Alexandra J Stewart; Jaroslaw T Hepel; Desmond A O'Farrell; Phillip M Devlin; Lori Lyn Price; Roger G Dale; David E Wazer
Journal:  Radiother Oncol       Date:  2013-07-25       Impact factor: 6.280

6.  Effect on therapeutic ratio of planning a boosted radiotherapy dose to the dominant intraprostatic tumour lesion within the prostate based on multifunctional MR parameters.

Authors:  S F Riches; G S Payne; N M Desouza; D Dearnaley; V A Morgan; S C Morgan; M Partridge
Journal:  Br J Radiol       Date:  2014-03-06       Impact factor: 3.039

Review 7.  Screening for prostate cancer: systematic review and meta-analysis of randomised controlled trials.

Authors:  Mia Djulbegovic; Rebecca J Beyth; Molly M Neuberger; Taryn L Stoffs; Johannes Vieweg; Benjamin Djulbegovic; Philipp Dahm
Journal:  BMJ       Date:  2010-09-14

8.  Analysis of equivalent uniform dose (EUD) and conventional radiation treatment parameters after primary and re-irradiation of malignant glioma.

Authors:  Maximilian Niyazi; Ivan Karin; Matthias Söhn; Silke B Nachbichler; Peter Lang; Claus Belka; Ute Ganswindt
Journal:  Radiat Oncol       Date:  2013-12-13       Impact factor: 3.481

9.  Dosimetric and clinical advantages of deep inspiration breath-hold (DIBH) during radiotherapy of breast cancer.

Authors:  Vicente Bruzzaniti; Armando Abate; Paola Pinnarò; Marco D'Andrea; Erminia Infusino; Valeria Landoni; Antonella Soriani; Carolina Giordano; Anna Ferraro; Lidia Strigari
Journal:  J Exp Clin Cancer Res       Date:  2013-11-07

10.  Methodological framework for estimating the correlation dimension in HRV signals.

Authors:  Juan Bolea; Pablo Laguna; José María Remartínez; Eva Rovira; Augusto Navarro; Raquel Bailón
Journal:  Comput Math Methods Med       Date:  2014-01-30       Impact factor: 2.238

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.